Symbol: |
SV2A
|
Description: |
synaptic vesicle glycoprotein 2A [Source:HGNC Symbol;Acc:20566]
|
Location: |
Chr1:149874870-149889434[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:213
Gene |
Compound |
Gen_sig |
Exp_pattern |
SV2A |
Camptothecin ethylglycinate ester hydrochloride |
0.004 |
Down |
SV2A |
RAPAMYCIN PRODRUG |
0.026 |
Down |
SV2A |
Camptothecin hemisuccinate sodium salt |
0.002 |
Down |
SV2A |
Camptothecin lysinate HCl |
0.002 |
Down |
SV2A |
Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- |
0.026 |
Down |
SV2A |
6H-Pyrido[4,3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-, (SP-4-1)-tetrachloroplatinate(2-) (2:1) |
0.001 |
Down |
SV2A |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.003 |
Down |
SV2A |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.03 |
Down |
SV2A |
14-FLUORO-4-DEMETHOXYDAUNORUBICIN |
0.018 |
Down |
SV2A |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.032 |
Down |
SV2A |
9-AMINO-20-CAMPTOTHECIN |
0.004 |
Down |
SV2A |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.028 |
Down |
SV2A |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.001 |
Down |
SV2A |
NSC 641594 |
0.033 |
Down |
SV2A |
1,4-BIS(DIETHYLAMINO)-5,8-DIHYDROXY ANTHRAQUINON |
0.006 |
Down |
Expression pattern: Sensitivity / Resistance
Total:15 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:42
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:48
Total:4 Current:1
[First] [Prev]  Next Last 
|